MedTrace Logo

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

NCT06890377 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-03-24

No results posted yet for this study

Summary

The aim of this study was to apply the targeted α-synuclein PET study technique to investigate the pathological load and spatial distribution characteristics of α-syn in MSA patients, and to assess its value as a biomarker for diagnostic typing, disease severity, and prognosis in MSA.

Conditions

  • Multiple System Atrophy - Cerebellar Subtype (MSA-C)
  • Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Sponsors & Collaborators

  • Min Zhao,MD

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-14
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06890377 on ClinicalTrials.gov